AU2986095A - A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus - Google Patents

A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus

Info

Publication number
AU2986095A
AU2986095A AU29860/95A AU2986095A AU2986095A AU 2986095 A AU2986095 A AU 2986095A AU 29860/95 A AU29860/95 A AU 29860/95A AU 2986095 A AU2986095 A AU 2986095A AU 2986095 A AU2986095 A AU 2986095A
Authority
AU
Australia
Prior art keywords
lesions
prevention
treatment
herpes virus
topical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29860/95A
Inventor
Amnon Sintov
Rina Uzan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Padagis Israel Pharmaceuticals Ltd
Original Assignee
Agis Industries 1983 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agis Industries 1983 Ltd filed Critical Agis Industries 1983 Ltd
Publication of AU2986095A publication Critical patent/AU2986095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
AU29860/95A 1994-07-20 1995-07-19 A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus Abandoned AU2986095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL110380 1994-07-20
IL11038094A IL110380A0 (en) 1994-07-20 1994-07-20 Antiviral topical pharmaceutical compositions
PCT/GB1995/001696 WO1996002244A1 (en) 1994-07-20 1995-07-19 A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus

Publications (1)

Publication Number Publication Date
AU2986095A true AU2986095A (en) 1996-02-16

Family

ID=11066363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29860/95A Abandoned AU2986095A (en) 1994-07-20 1995-07-19 A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus

Country Status (3)

Country Link
AU (1) AU2986095A (en)
IL (1) IL110380A0 (en)
WO (1) WO1996002244A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787490A1 (en) * 1996-01-31 1997-08-06 Agis Industries (1983) Ltd A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
US6197743B1 (en) 1996-07-26 2001-03-06 The Trustees Of Boston University Compositions and methods for the treatment of viral disorders
WO1998004290A2 (en) * 1996-07-26 1998-02-05 Perrine Susan P Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
EP0941087B1 (en) 1996-11-14 2009-09-16 Lipomedica ehf. Topical formulations containing as a therapeutic active agent a monoglyceride for treating of mucosa infections
SE520811C2 (en) * 1997-01-17 2003-08-26 Ponsus Ab Skin protection preparations containing lipophilic and hydrophilic components, method of preparation and use thereof
AU774861B2 (en) 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
DE19853487A1 (en) 1998-11-19 2000-05-25 Fumapharm Ag Muri Use of dialkyl fumarate for treating transplant rejection and autoimmune disease
PL392748A1 (en) 2001-01-12 2011-05-09 Fumapharm Ag Fumaric acid amides
DE10101307A1 (en) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumaric acid derivatives as NF-kappaB inhibitor
JP2004531629A (en) 2001-06-22 2004-10-14 エクソンモービル・ケミカル・パテンツ・インク Ultra-low density polyethylene or linear low density polyethylene as impact modifier made by metallocene
US20030018074A1 (en) * 2001-07-06 2003-01-23 Robert Kleiman Antiviral composition and treatment method
CA2488983A1 (en) 2002-07-31 2004-02-19 Exxonmobil Chemical Patents Inc. Silane crosslinkable polyethylene
DE60321007D1 (en) 2002-09-05 2008-06-26 Exxonmobil Chem Patents Inc Shrink film
EP1539866B1 (en) 2002-09-05 2011-01-05 ExxonMobil Chemical Patents Inc. Method for wrapping an article with a stretch film
EP1430891A1 (en) * 2002-12-19 2004-06-23 Elisabeth Fleischmann Oil-acid-emulsion for the treatment of joint diseases and for the stimulation of blood-circulation
US7709577B2 (en) 2005-12-07 2010-05-04 Exxonmobil Chemical Patents Inc. Process of making polymer blends
US7951873B2 (en) 2006-05-05 2011-05-31 Exxonmobil Chemical Patents Inc. Linear low density polymer blends and articles made therefrom
US7256240B1 (en) 2006-12-22 2007-08-14 Exxonmobil Chemical Patents Inc. Process of making polymer blends
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
WO2011072086A1 (en) 2009-12-08 2011-06-16 Hemaquest Pharmaceuticals, Inc. Methods and low dose regimens for treating red blood cell disorders
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
US10316176B2 (en) 2012-02-03 2019-06-11 Exxonmobil Chemical Patents Inc. Polymer compositions and methods of making them
US9139794B2 (en) 2012-02-03 2015-09-22 Exxonmobil Chemical Patents Inc. Process for the production of polymeric compositions useful as oil modifiers
CN109135034A (en) 2012-02-03 2019-01-04 埃克森美孚化学专利公司 It can be used for the preparation method of the polymer composition of oil plant modifying agent
EP3976198A4 (en) 2019-05-31 2023-07-19 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78168A1 (en) * 1977-09-22 1979-05-25 F Genieyz SKIN TREATMENT COMPOSITION AND PREPARATION METHOD
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4520132A (en) * 1982-09-27 1985-05-28 Pennwalt Corporation Use of undecylenic acid to treat herpes labialis
GB8603621D0 (en) * 1986-02-14 1986-03-19 Habib N Modifying lipid structure of cell membranes
DE3623862A1 (en) * 1986-07-11 1988-01-21 Schering Ag USE OF DICARBONIC ACIDS WITH 7 - 13 CARBON ATOMS OR PHYSIOLOGICALLY COMPATIBLE SALTS THEREOF FOR TOPICAL TREATMENT OF ROSAZEA
FI912955A (en) * 1990-06-25 1991-12-26 Res Found Mental Hygiene ANTIMIKROBA FETTSYRASAMMANSAETTNINGAR.
NZ252895A (en) * 1992-06-08 1996-10-28 Pitmy Int Nv Dermatological compositions containing nitrous oxide and at least one essential fatty acid or ester thereof, optionally with other ingredients
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate

Also Published As

Publication number Publication date
IL110380A0 (en) 1994-10-21
WO1996002244A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
AU2986095A (en) A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
AU2103097A (en) Cinnoline derivatives and use as medicine
AU4516796A (en) Chitosan salts and process for the preparation thereof
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AP9801386A0 (en) Antimicrobial treatment for herpes simplex virus and other infectious diseases
AU663637B2 (en) Solutions and their preparation
AU1609395A (en) Positive locking cannula
AU7319994A (en) Nucleotide preparation and uses thereof in wound healing
AU4357393A (en) Prophylactic and remedy for viral diseases in respiratory tract
AUPM740594A0 (en) Anti-inflammatory preparation
AU5804494A (en) Preparation and transfer sheet
AU6367496A (en) New hormonal medicaments and their use for the correction of oestrogenic deficiencies
AU1811597A (en) Triterpene derivatives and remedies for liver diseases
AU5666994A (en) T-configured wheelchair
AU7001796A (en) Benzoic acid compounds and medicinal use thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU5425098A (en) Compounds and methods to treat infectious diseases
AU1475595A (en) Pharmaceutical preparation
AU691677B2 (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
AU4947993A (en) Combretastatin derivatives with antitumoral activity and process for the preparation thereof
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
AU3691497A (en) A medicine of external use for treating seborrheic baldness with high efficacy and low side effect and preparation thereof
AU2783697A (en) Topical medicament comprising phenolic biocide and choline
AU5682594A (en) Low denier polybenzazole fibers and the preparation thereof